The global substance use disorder treatment market is on a robust growth trajectory, with sales expected to soar to USD 40.3 billion in 2024. Over the next decade, the market is forecasted to expand ...

The Asia Pacific Preventive Vaccines Market is experiencing a transformative surge, with its valuation leaping from USD 20.9 billion in 2023 to a projected USD 63.11 billion by 2032, growing at a ...

Market OverviewThe global Vaccines Market has evolved significantly in recent years, driven by advancements in biotechnology, ...

London stocks closed sharply lower on Thursday as global markets reacted negatively to US president Donald Trump's unexpectedly aggressive global tariff policy announced overnight. The FTSE 100 index ...

London stocks were still sharply lower by midday on Thursday as Donald Trump’s more aggressive than expected tariff ...

In the latest in a growing trend of pharma reshuffling moves in Asia, Marubeni Corporation is absorbing Sumitomo Pharma’s ...

Economic Access: Southeast Asia’s digital economy is projected to reach $2 trillion by 2030. US firms that invest early will ...

Silicon Valley has been a universal symbol of innovation for decades. Because of its reputation, governments around the world ...

AstraZeneca, GSK & partners will source 225GWh of renewable power in China, cutting emissions by 250,000 tonnes – equal to ...

The European antibiotics market was valued at $11,561 million in 2019, and is projected to reach $13,529 million by 2027 at a CAGR of 1.9% from 2020 to 2027. There is an increase in the demand for ...

It told the stock exchange on Monday that unit Jollibee Worldwide Pte Ltd. had tapped J.P. Morgan Securities Asia Private Ltd. and Morgan Stanly Asia (Singapore) Pte as joint global coordinators and ...